Illumina's TruPath™ Genome combines proximity-mapped read technology with DRAGEN™ informatics to unlock comprehensive, haplotype-resolved genomic insights—including phased small variants, structural variants, paralogous gene resolution, and accurate STR sizing—using existing short-read sequencing infrastructure with just ~10 minutes of hands-on time.